GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein

Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions

(2022) Monica Imbernon et al.   Cell Metabolism

Fasting plasma GLP-1 associates with overweight/obesity and cardiometabolic risk factors in children and adolescents

(2021) Sara E Stinson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs

(2021) Dario Giugliano et al.   Cardiovascular Diabetology

Increased of fasting active glucagon-like peptide-1 is associated with insulin resistance in patients with hypertriglyceridemia

(2021) Lujie Zhao et al.   International Journal of Diabetes in Developing Countries

Vagal afferent cholecystokinin receptor activation is required for glucagon‐like peptide‐1–induced satiation

(2021) Vasiliki Vana et al.   DIABETES OBESITY & METABOLISM

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

(2020) Michael A. Nauck et al.   Molecular Metabolism

Using a reporter mouse to map known and novel sites of GLP-1 receptor expression in peripheral tissues of male mice

(2020) Daniel B Andersen et al.   ENDOCRINOLOGY

Rapid hepatic metabolism blunts the endocrine action of portally infused GLP-1 in male rats

(2019) Benedikt A Aulinger et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides/bile acids in adolescents with obesity

(2019) Victoria Higgins et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Profiling of G protein-coupled receptors in vagal afferents reveals novel gut-to-brain sensing mechanisms

(2018) Kristoffer L. Egerod et al.   Molecular Metabolism

Gut peptide and neuroendocrine regulation of hepatic lipid and lipoprotein metabolism in health and disease

(2018) Danielle Alvares et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

A Nigro−Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism

(2017) Laura Anselmi et al.   GASTROENTEROLOGY

Glucagon-like peptide-1 and insulin synergistically activate vagal afferent neurons

(2017) Yusaku Iwasaki et al.   NEUROPEPTIDES

Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men

(2017) N. Matikainen et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Unimolecular Polypharmacy for Treatment of Diabetes and Obesity

(2016) Matthias H. Tschöp et al.   Cell Metabolism

Endogenous Glucagon-like Peptide-1 Receptor Signaling in the Nucleus Tractus Solitarius is Required for Food Intake Control

(2016) Amber L Alhadeff et al.   NEUROPSYCHOPHARMACOLOGY

Is GLP-1 a hormone: Whether and When?

(2016) David D'Alessio   Journal of Diabetes Investigation

Central Nervous System Regulation of Intestinal Lipoprotein Metabolism by Glucagon-Like Peptide-1 via a Brain-Gut Axis

(2015) S. Farr et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

One-day high-fat diet induces inflammation in the nodose ganglion and hypothalamus of mice

(2015) T. M. Zaved Waise et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia

(2015) Jean-Philippe Krieger et al.   DIABETES

Vagal mediation of GLP-1's effects on food intake and glycemia

(2015) Jean-Philippe Krieger et al.   PHYSIOLOGY & BEHAVIOR

The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra

(2014) L.-F. Zheng et al.   Acta Physiologica

GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance

(2014) Jennifer Taher et al.   Molecular Metabolism

Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways

(2013) Makoto Nishizawa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Combination of Obesity and High-Fat Feeding Diminishes Sensitivity to GLP-1R Agonist Exendin-4

(2013) F. A. Duca et al.   DIABETES

Insulin Acutely Inhibits Intestinal Lipoprotein Secretion in Humans in Part by Suppressing Plasma Free Fatty Acids

(2009) M. Pavlic et al.   DIABETES